Willkie Shortlisted in Six Categories for The Deal Awards 2020

The Deal has named Willkie a finalist in several categories for The Deal Awards 2020, recognizing leading lawyers, bankers, investors and advisers in large-cap transactions. The firm and several attorneys individually are recognized as finalists for the following awards:

  • Financial Services Law Firm of the Year – Willkie
  • Healthcare, Pharma & Biotech Law Firm of the Year – Willkie
  • Dealmaker of the Year – Adam Turteltaub
  • Private Equity Dealmaker of the Year – Jeffrey Poss
  • Financial Services Dealmaker of the Year – Robert Rachofsky
  • Healthcare, Pharma & Biotech Dealmaker of the Year – Neil Townsend

Additionally, the firm is recognized for its representation in the following shortlisted deals:

  • Cross-border Deal of the Year; Most Innovative Deal of the Year:
    Mylan acquires Upjohn from Pfizer to form Viatris
    Acquirer: Counsel to I-banks – Willkie
  • Healthcare, Pharma & Biotech Deal of the Year:
    Partners Group takes majority stake in EyeCare Partners from FFL Partners
    Target/Seller: Outside Counsel – Willkie

Awards will be presented at a virtual ceremony to be held on Sept. 25, 2020.